Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Active Not Recruiting Phase 2 Trials for Busulfan (DB01008)

IndicationStatusPhase
DBCOND0031216 (Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01168219Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid LeukemiaTreatment